{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:18:01Z","timestamp":1787865481980,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018817","name":"Lupus UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR GOSH BRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["MISP program"],"award-info":[{"award-number":["MISP program"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ard.2026.07.024","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:18:16Z","timestamp":1787426296000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro"],"prefix":"10.1016","author":[{"given":"Yves","family":"Renaudineau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mizgalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Roachdown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Cusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Kinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Karolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Charras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-6179","authenticated-orcid":false,"given":"Christian M","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam","family":"Al-Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Armon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Gardner-Medwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"McErlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Modgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimalaipet V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyapal","family":"Rangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.07.024_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","article-title":"Systemic lupus erythematosus in children and young people","volume":"23","author":"Charras","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/BOR.0000000000000913","article-title":"Current views on lupus in children","volume":"35","author":"Smith","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2026.07.024_bib0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups","volume":"29","author":"Massias","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2026.07.024_bib0005","doi-asserted-by":"crossref","first-page":"109028","DOI":"10.1016\/j.clim.2022.109028","article-title":"Real world treatment of juvenile-onset systemic lupus erythematosus: data from the UK JSLE cohort study","volume":"239","author":"Smith","year":"2022","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.ard.2026.07.024_bib0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.berh.2018.02.001","article-title":"Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options","volume":"31","author":"Hedrich","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ard.2026.07.024_bib0007","doi-asserted-by":"crossref","first-page":"108937","DOI":"10.1016\/j.clim.2022.108937","article-title":"Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis","volume":"236","author":"Bost","year":"2022","journal-title":"Clin Immunol"},{"issue":"7909","key":"10.1016\/j.ard.2026.07.024_bib0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-024-01660-6","article-title":"Interface gain-of-function mutations in TLR7 cause systemic and neuro-inflammatory disease","volume":"44","author":"David","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ard.2026.07.024_bib0010","doi-asserted-by":"crossref","first-page":"103451","DOI":"10.1016\/j.jaut.2025.103451","article-title":"Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus","volume":"155","author":"Renaudineau","year":"2025","journal-title":"J Autoimmun"},{"issue":"92","key":"10.1016\/j.ard.2026.07.024_bib0011","doi-asserted-by":"crossref","first-page":"eadi9769","DOI":"10.1126\/sciimmunol.adi9769","article-title":"UNC93B1 variants underlie TLR7-dependent autoimmunity","volume":"9","author":"Wolf","year":"2024","journal-title":"Sci Immunol"},{"issue":"92","key":"10.1016\/j.ard.2026.07.024_bib0012","doi-asserted-by":"crossref","first-page":"eadi9575","DOI":"10.1126\/sciimmunol.adi9575","article-title":"Disrupted degradative sorting of TLR7 is associated with human lupus","volume":"9","author":"Mishra","year":"2024","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.200612056","article-title":"The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling","volume":"177","author":"Brinkmann","year":"2007","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.ard.2026.07.024_bib0014","doi-asserted-by":"crossref","first-page":"102361","DOI":"10.1016\/j.autrev.2019.102361","article-title":"Monogenic lupus: dissecting heterogeneity","volume":"18","author":"Omarjee","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0015","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1016\/S2665-9913(19)30142-0","article-title":"Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts","volume":"2","author":"Belot","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"14526","key":"10.1016\/j.ard.2026.07.024_bib0016","article-title":"Lupus nephritis risk factors and biomarkers: an update","volume":"24","author":"Renaudineau","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ard.2026.07.024_bib0017","doi-asserted-by":"crossref","first-page":"100199","DOI":"10.1016\/j.jtauto.2023.100199","article-title":"Immunological and translational key challenges in systemic lupus erythematosus: a symposium update","volume":"6","author":"Renaudineau","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.ard.2026.07.024_bib0018","doi-asserted-by":"crossref","first-page":"100200","DOI":"10.1016\/j.jtauto.2023.100200","article-title":"Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus","volume":"6","author":"Renaudineau","year":"2023","journal-title":"J Transl Autoimmun"},{"issue":"SI2","key":"10.1016\/j.ard.2026.07.024_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac275","article-title":"Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE","volume":"62","author":"Charras","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ard.2026.07.024_bib0020","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ard.2026.07.024_bib0021","doi-asserted-by":"crossref","first-page":"1006761","DOI":"10.3389\/fimmu.2022.1006761","article-title":"The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation","volume":"13","author":"Puissant-Lubrano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ard.2026.07.024_bib0022","doi-asserted-by":"crossref","first-page":"151998","DOI":"10.1016\/j.semarthrit.2022.151998","article-title":"Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot","volume":"55","author":"Bories","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ard.2026.07.024_bib0023","doi-asserted-by":"crossref","first-page":"108774","DOI":"10.1016\/j.clim.2021.108774","article-title":"Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis","volume":"229","author":"Bost","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ard.2026.07.024_bib0024","doi-asserted-by":"crossref","first-page":"108908","DOI":"10.1016\/j.clim.2021.108908","article-title":"Lupus band test can be used in combination with anti-chromatin antibodies and complement analysis to predict transition from cutaneous to systemic lupus","volume":"234","author":"Carle","year":"2022","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.ard.2026.07.024_bib0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3899\/jrheum.220513","article-title":"Genome-wide sequencing identified rare genetic variants for childhood-onset monogenic lupus","volume":"50","author":"Misztal","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ard.2026.07.024_bib0026","doi-asserted-by":"crossref","first-page":"108314","DOI":"10.1016\/j.clim.2019.108314","article-title":"Linking genetic variation with epigenetic profiles in Sjogren's syndrome","volume":"210","author":"Arvaniti","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ard.2026.07.024_bib0027","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fimmu.2015.00437","article-title":"An in silico approach reveals associations between genetic and epigenetic factors within regulatory elements in B cells from primary sjogren's syndrome patients","volume":"6","author":"Konsta","year":"2015","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41594-020-00542-w","article-title":"Cryo-EM structures of Toll-like receptors in complex with UNC93B1","volume":"28","author":"Ishida","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0029","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.ard.2026.07.024_bib0030","series-title":"Protein preparation workflow","year":"2024"},{"key":"10.1016\/j.ard.2026.07.024_bib0031","series-title":"Impact","year":"2025"},{"key":"10.1016\/j.ard.2026.07.024_bib0032","series-title":"Prime","year":"2025"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0033","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"Sondergaard","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ard.2026.07.024_bib0034","doi-asserted-by":"crossref","first-page":"112978","DOI":"10.1016\/j.ejmech.2020.112978","article-title":"Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations","volume":"210","author":"Pal","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0035","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ard.2026.07.024_bib0036","series-title":"Desmond molecular dynamics system","year":"2024"},{"key":"10.1016\/j.ard.2026.07.024_bib0037","series-title":"Maestro-desmond interoperability tools","year":"2025"},{"key":"10.1016\/j.ard.2026.07.024_bib0038","doi-asserted-by":"crossref","first-page":"729513","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: the WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"6126","key":"10.1016\/j.ard.2026.07.024_bib0039","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1126\/science.1229159","article-title":"Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands","volume":"339","author":"Tanji","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ard.2026.07.024_bib0040","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0041","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/eji.200535806","article-title":"Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides","volume":"36","author":"Jurk","year":"2006","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.ard.2026.07.024_bib0042","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat Genet"},{"issue":"37","key":"10.1016\/j.ard.2026.07.024_bib0043","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.1408023111","article-title":"Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling","volume":"111","author":"Hedrich","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"50","key":"10.1016\/j.ard.2026.07.024_bib0044","doi-asserted-by":"crossref","first-page":"43429","DOI":"10.1074\/jbc.M111.299339","article-title":"cAMP-responsive element modulator (CREM)alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus","volume":"286","author":"Hedrich","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ard.2026.07.024_bib0045","doi-asserted-by":"crossref","first-page":"110194","DOI":"10.1016\/j.clim.2024.110194","article-title":"Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus","volume":"262","author":"Renaudineau","year":"2024","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.ard.2026.07.024_bib0046","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1471-4906(03)00242-4","article-title":"Leucine-rich repeats and pathogen recognition in Toll-like receptors","volume":"24","author":"Bell","year":"2003","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0047","doi-asserted-by":"crossref","first-page":"e20250194","DOI":"10.70962\/jhi.20250194","article-title":"Identification of a novel TLR7 gain-of-function variant that underlies systemic lupus erythematosus","volume":"2","author":"Sethumadhavan","year":"2026","journal-title":"J Hum Immun"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0048","doi-asserted-by":"crossref","first-page":"e20250194","DOI":"10.70962\/jhi.20250194","article-title":"Identification of a novel TLR7 gain-of-function variant that underlies systemic lupus erythematosus","volume":"2","author":"Sethumadhavan","year":"2026","journal-title":"J Hum Immun"},{"issue":"62","key":"10.1016\/j.ard.2026.07.024_bib0049","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ard.2026.07.024_bib0050","doi-asserted-by":"crossref","first-page":"103428","DOI":"10.1016\/j.autrev.2023.103428","article-title":"What is the best instrument to measure disease activity in SLE? - SLE-DAS vs Easy BILAG","volume":"23","author":"Ines","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.ard.2026.07.024_bib0051","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/pro.4043","article-title":"Structural and functional understanding of the toll-like receptors","volume":"30","author":"Asami","year":"2021","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.ard.2026.07.024_bib0052","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12929-019-0584-z","article-title":"Beyond defense: regulation of neuronal morphogenesis and brain functions via Toll-like receptors","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"issue":"15","key":"10.1016\/j.ard.2026.07.024_bib0053","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ard.2026.07.024_bib0054","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41435-021-00157-1","article-title":"Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients","volume":"23","author":"Mantovani","year":"2022","journal-title":"Genes Immun"},{"key":"10.1016\/j.ard.2026.07.024_bib0055","doi-asserted-by":"crossref","first-page":"106209","DOI":"10.1016\/j.ebiom.2026.106209","article-title":"Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases","volume":"126","author":"Tusseau","year":"2026","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0056","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/BOR.0000000000001072","article-title":"Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus","volume":"37","author":"Charras","year":"2025","journal-title":"Curr Opin Rheumatol"},{"issue":"13","key":"10.1016\/j.ard.2026.07.024_bib0057","doi-asserted-by":"crossref","first-page":"e179193","DOI":"10.1172\/JCI179193","article-title":"A de novo TLR7 gain-of-function mutation causing severe monogenic lupus in an infant","volume":"134","author":"Stremenova Spegarova","year":"2024","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0058","doi-asserted-by":"crossref","first-page":"e20250266","DOI":"10.70962\/jhi.20250266","article-title":"TLR7 mutations leading to enhanced TLR7 signaling in humans","volume":"2","author":"Crow","year":"2026","journal-title":"J Hum Immun"},{"key":"10.1016\/j.ard.2026.07.024_bib0059","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.coi.2025.102608","article-title":"Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus","volume":"96","author":"Lin","year":"2025","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.05.017","article-title":"The brain microvasculature is a primary mediator of interferon-alpha neurotoxicity in human cerebral interferonopathies","volume":"57","author":"Viengkhou","year":"2024","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ard.2026.07.024_bib0062","doi-asserted-by":"crossref","first-page":"e20232005","DOI":"10.1084\/jem.20232005","article-title":"Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans","volume":"221","author":"Rael","year":"2024","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0063","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-021-00559-9","article-title":"Toll-like receptors form different complexes with UNC93B1","volume":"28","author":"Rael","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0064","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4049\/immunohorizons.2000002","article-title":"TLR7 and TLR8 differentially activate the IRF and NF-kappaB pathways in specific cell types to promote inflammation","volume":"4","author":"Bender","year":"2020","journal-title":"Immunohorizons"},{"issue":"2","key":"10.1016\/j.ard.2026.07.024_bib0065","first-page":"92","article-title":"Expression and activation of intracellular receptors TLR7, TLR8 and TLR9 in peripheral blood monocytes from HIV-infected patients","volume":"44","author":"Valencia Pacheco","year":"2013","journal-title":"Colomb M\u00e9d (Cali)"},{"issue":"1","key":"10.1016\/j.ard.2026.07.024_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-011-0234-3","article-title":"Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic intervention","volume":"12","author":"Horton","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ard.2026.07.024_bib0067","doi-asserted-by":"crossref","first-page":"1046687","DOI":"10.3389\/fphar.2022.1046687","article-title":"Targeting type I interferons in systemic lupus erythematous","volume":"13","author":"Bruera","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ard.2026.07.024_bib0068","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12026-023-09367-3","article-title":"Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study","volume":"71","author":"In 't Veld","year":"2023","journal-title":"Immunol Res"},{"issue":"12","key":"10.1016\/j.ard.2026.07.024_bib0069","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/eji.200737815","article-title":"Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms","volume":"37","author":"Barrat","year":"2007","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.ard.2026.07.024_bib0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.ard.2026.07.024_bib0071","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ard.2026.07.024_bib0072","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ard.2026.07.024_bib0073","doi-asserted-by":"crossref","first-page":"777197","DOI":"10.3389\/fimmu.2021.777197","article-title":"Anti-TLR7 antibody protects against lupus nephritis in NZBWF1 mice by targeting B cells and patrolling monocytes","volume":"12","author":"Murakami","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ard.2026.07.024_bib0074","doi-asserted-by":"crossref","first-page":"101036","DOI":"10.1016\/j.xcrm.2023.101036","article-title":"Preclinical characterization of the Toll-like receptor 7\/8 antagonist MHV370 for lupus therapy","volume":"4","author":"Hawtin","year":"2023","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.ard.2026.07.024_bib0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.123.001744","article-title":"Preclinical evidence for the glucocorticoid-sparing potential of a dual toll-like receptor 7\/8 inhibitor in autoimmune diseases","volume":"388","author":"Deshmukh","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ard.2026.07.024_bib0076","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.202149361","article-title":"Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells","volume":"52","author":"Cenac","year":"2022","journal-title":"Eur J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:10Z","timestamp":1787862250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726004826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"alternative-id":["S0003496726004826"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.024","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}